Apellis Pharmaceuticals
APLS
$52.34
Share price
-0.84%
Change (1 day)
29.54%
Change (1 year)
Revenue for Apellis Pharmaceuticals (APLS)
Revenue in 2022 (TTM): $0.11 B
According to Apellis Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.11 B. In 2021 the company made a revenue of $66.56 M a decrease over the years 2020 revenue that were of $0.25 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Apellis Pharmaceuticals from 2017 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $0.11 B | 69.84% |
| 2021 | $66.56 M | -73.44% |
| 2020 | $0.25 B | INF% |
| 2019 | N/A | NAN% |
| 2018 | N/A | NAN% |
| 2017 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | -100.00% | 🇺🇸 USA |